NDC 82260-466 – Besivance

Besifloxacin 6 mg/mL · Suspension · Ophthalmic

Human Prescription Drug

Product NDC82260-466

Product details

Brand name
Besivance
Generic name
Besifloxacin
Labeler
Bausch & Lomb Americas Inc.
Dosage form
Suspension
Route
Ophthalmic
Marketing category
NDA · NDA022308
Marketed since
January 9, 2026
Listing expires
December 31, 2027
Pharmacologic class
Quinolone Antimicrobial

Active ingredients

Uses, dosage, side effects and warnings for Besivance →

Package NDC codes (1)

Package NDCDescriptionSince
82260-466-051 BOTTLE, DROPPER in 1 CARTON (82260-466-05) / 5 mL in 1 BOTTLE, DROPPERJan 9, 2026

Other Besivance products